References
- 1SulicaLLouisEDClinical characteristics of essential voice tremor: a study of 34 casesLaryngoscope201012051652810.1002/lary.2070220066728
- 2GureyLESinclairCFBlitzerAA new paradigm for the management of essential vocal tremor with botulinum toxinLaryngoscope20131232497250123553653
- 3BrinMFBlitzerAStewartCLaryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxinAdv Neurol1998782372529750921
- 4LudlowCLAdlerCHBerkeGSet alResearch priorities in spasmodic dysphoniaOtolaryngol Head Neck Surg200813949550510.1016/j.otohns.2008.05.62418922334
- 5SimonyanKLudlowCLAbnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI studyCereb Cortex2010202749275910.1093/cercor/bhq02320194686
- 6AliSOThomassenMSchulzGMet alAlterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET studyJ Speech Lang Hear Res2006491127114610.1044/1092-4388(2006/081)17077220
- 7FruchtSJBordelonYHoughtonWHReardanDA pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disordersMov Disord2005201330133710.1002/mds.2060515986420
- 8FruchtSJHoughtonWCBordelonYGreenePELouisEDA single-blind, open-label trial of sodium oxybate for myoclonus and essential tremorNeurology2005651967196910.1212/01.wnl.0000188670.38576.bd16382538
- 9CrunelliVErnriZLerescheNUnravelling the brain targets of gamma-hydroxybutyric acidCurr Opin Pharmacol20066445210.1016/j.coph.2005.10.00116368267
- 10LevyLMZiemannUChenRCohenLGRapid modulation of GABA in sensorimotor cortex induced by acute deafferentationAnn Neurol20025275576110.1002/ana.1037212447929
- 11MarjanskaMLehericySValabregueRet alBrain dynamic neurochemical changes in dystonic patients: a magnetic resonance spectroscopy studyMovement Disord20132820120910.1002/mds.2527923239076
- 12HallettMNeurophysiology of dystonia: the role of inhibitionNeurobiol Dis20114217718410.1016/j.nbd.2010.08.02520817092